Results
1 -
10 of
14
(Click
here to explore results)
Drug Discovery for Schizophrenia, CHAPTER 4 The Self-medication Hypothesis in Schizophrenia: What Have We Learned from Animal Models? . Bernard Le Foll, Enoch Ng, José M. Trigo, Patricia Di Ciano
, 2015
, Pages 70-88
Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 6 D3 Receptor Agonists and Antagonists as Anti‐Parkinsonian Therapeutic Agents . Mark Johnson, Aloke Dutta
, 2013
, Pages 126-148
G Protein-Coupled Receptors: From Structure to Function, Chapter 6 Ligand Regulation of GPCR Quaternary Structure . L. Saenz del Burgo, G. Milligan
, 2011
, Pages 111-152
Drug Discovery for Schizophrenia, CHAPTER 8 GSK3 Networks in Schizophrenia . Jivan Khlghatyan, Gohar Fakhfouri, Jean-Martin Beaulieu
, 2015
, Pages 173-201
Drug Discovery for Schizophrenia, Subject Index
, 2015
, Pages 273-289
Aging and Vulnerability to Environmental Chemicals: Age-related Disorders and Their Origins in Enviromental Exposures, CHAPTER 6 Manganese . Roberto G Lucchini, Donald R. Smith, Ronald B Tjalkens
, 2013
, Pages 151-181
The Discovery and Utility of Chemical Probes in Target Discovery, CHAPTER 10 Assays to Characterize the Cellular Pharmacology of a Chemical Probe . Jakub Stefaniak, Sébastien R. G. Galan, Kilian V. M. Huber
, 2021
, Pages 247-275
Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 5 Pyrazoles . Carsten S. Kramer
, 2016
, Pages 115-131
Animal Models for Neurodegenerative Disease, Chapter 6 Animal Models of Parkinson's Disease . Hardy J. Rideout, Leonidas Stefanis
, 2011
, Pages 86-112
Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 7 Protein Phosphatases in Parkinson’s Disease . Petr Heneberg
, 2013
, Pages 149-171